Val R. Adams

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

Xiaowei Dong, Cynthia A. Mattingly, Michael T. Tseng et al. · Cancer Research · 2009 · 285 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +12

DELAYED GRAFT FUNCTION AFTER RENAL TRANSPLANTATION1

William Pfaff, Richard J. Howard, Pamela R. Patton et al. · Transplantation · 1998 · 126 citations

Medicine, Surgery, Kidney Transplantation +12

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

Aimee K. Bence, Eric B. Anderson, Maqbool Halepota et al. · Investigational New Drugs · 2004 · 122 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization

Xiaowei Dong, Cynthia A. Mattingly, Michael T. Tseng et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2008 · 96 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +14

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment

Joshua D. Brown, Amie Goodin, Gregory Y.H. Lip et al. · Journal of the American Heart Association · 2018 · 93 citations · Full text

Medicine, Hematology, Clinical Epidemiology +16